Response rate of anticancer drugs approved by the Food and Drug Administration based on a single-arm trial

BACKGROUND: In recent years, an increasing number of anticancer drugs have been approved based on the results of a single-arm trial (SAT). The magnitude of the objective response rate (ORR) in SATs is important for regulatory decisions, but there has been no clear guidance specifying the degree of O...

Descripción completa

Detalles Bibliográficos
Autores principales: Oda, Yoshihiro, Narukawa, Mamoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922846/
https://www.ncbi.nlm.nih.gov/pubmed/35291959
http://dx.doi.org/10.1186/s12885-022-09383-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922846/
https://www.ncbi.nlm.nih.gov/pubmed/35291959
http://dx.doi.org/10.1186/s12885-022-09383-w

Ejemplares similares